However, UOB notes that the spread between TJZX’s S-shares listed on the Singapore Exchange (SGX) and its A-shares listed on the Shanghai Stock Exchange (SSE) have been steadily widening since May.
SINGAPORE (May 21): UOB Kay Hian is keeping its “buy” call on Tianjin Zhong Xin Pharmaceutical Group Corporation (TJZX) with an unchanged target price of US$1.72 – representing an upside of 43%.
Shares in the Chinese pharmaceutical firm have already climbed some 20% to US$1.20 as at 10.23am on Monday since it announced a stellar 1Q18 on Apr 27.
